Effect of Omega 3 supplementation in women with polycystic ovary syndrome

Not Applicable

• Conditions: polycystic ovary syndrome.; Sclerocystic ovary syndrome Stein-Leventhal syndrome

• Registration Number: IRCT2012071410281N1
• Lead Sponsor: Institute for Reproductive Sciences, Research and clinical Center for Infertility

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 64

Inclusion Criteria

criteria inclusion:
females 20-40years; PCOS diagnostic according to Roterdam criteria; BMI>25; No history about intake of any drug during the last 3 months that may affect the insulin sensitivity or hormonal profile such as: oral contraceptives, glucocorticoids, ovulation induction agents, anti diabetic and anti obesity drugs, estrogenic, antiandrogenic or anti hypertensive medication; Not being in any diet in the last 3month; Do not have any addiction to tobacco and alcohol; Do not taking a Omega-3 supplement in the last 3 month; Do not be menopause; Do not use anti-coagulant medicine; Do not use anti-depression medication; Do not be diabetic and hypothyroidism.

exclusion criteria:

Essentially needs for intake of OCP to treatment; Do not will to be in the study; Do not obey the Protocols of the study and do not digest more than 20% of supplements.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum visfatin-. Timepoint: before and after intervention. Method of measurement: visfatin ng/ml Elisa kit-.;Serum adiponectin. Timepoint: before and after intervention. Method of measurement: adiponectin Elisa kit µg/ml-.;Serum LH. Timepoint: before and after intervention. Method of measurement: LH Elisa kit U/l.;Serum FSH. Timepoint: before and after intervention. Method of measurement: FSHElisa kit U/l-.;Serum Prolactin. Timepoint: before and after intervention. Method of measurement: prolactin Elisa ng/mL.;Body weight. Timepoint: before and after intervention. Method of measurement: leveled platform scale.;BMI-. Timepoint: before and after intervention. Method of measurement: leveled platform scale-stadiometer.;Waist circumference. Timepoint: before and after intervention. Method of measurement: tape.;Hip circumference. Timepoint: before and after intervention. Method of measurement: tape.